Arjun Goyal

Arjun Goyal is the founder of Vida Ventures, founded in 2017; Affini-T Therapeutics, Inc., founded in 2021; and VV Manager LLC, founded in 2017, where the title held is Managing Director.
Current jobs include Director at AskBio Inc., Independent Director at JATT II Acquisition Corp., Board of Director at Quanta Therapeutics, Inc. since 2020, Board of Director at Scorpion Therapeutics, Inc. since 2020, and Director at Alterome Therapeutics, Inc. since 2021.
Former jobs include Director at Peloton Therapeutics, Inc. and Pionyr Immunotherapeutics, Inc., Member Board Of Director at Kinnate Biopharma, Inc. from 2019 to 2020, Independent Non-Executive Director at Centessa Pharmaceuticals Plc from 2021 to 2026, Principle at 5AM Venture Management LLC from 2014 to 2017, and Interim Vice President at Pear Therapeutics (US), Inc. from 2014 to 2016.
Education includes undergraduate and doctorate degrees from the University of Melbourne, an undergraduate degree from the University of Oxford, a graduate degree from the University of Cambridge, and an MBA from Harvard Business School conferred in 2014.